Skip to content

13F-HR filed by Omega Fund Management, LLC

Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2015-12-31, filed 2016-02-10, with 10 holding rows worth $179,685,000.

Accession
0000950123-16-013919
Filed
2016-02-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2015

A holdings report, 10 entries on the cover page, a total value of $179,685,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $179,685,000 with VALUE read as thousands by filing date, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
JUNO THERAPEUTICS INC48205A109COM1,229,512$54,062,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity2,138,872$40,574,000thousands by filing date
EGALET CORP28226B104COM2,814,928$31,021,000thousands by filing date
FIBROGEN INC31572Q808COM822,175$25,052,000thousands by filing date
NABRIVA THERAPEUTICS AG62957M104SPONSORED ADR1,145,890$11,023,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM2,483,949$5,688,000thousands by filing date
ESSA PHARMA INC29668H104COM1,090,909$4,636,000thousands by filing date
PROTEON THERAPEUTICS INC74371L109COM250,000$3,878,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM223,457$2,652,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM650,000$1,099,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-16-013919this filing2016-02-10acceptance time not in the bulk data set